Sulfonylurea News and Research

RSS
GlaxoSmithKline response to JAMA article on ICES retrospective analysis

GlaxoSmithKline response to JAMA article on ICES retrospective analysis

GlaxoSmithKline implements changes to the US product label for Avandia

GlaxoSmithKline implements changes to the US product label for Avandia

FDA adds warning for heart attacks to type 2 diabetes drug Avandia

FDA adds warning for heart attacks to type 2 diabetes drug Avandia

Impact of various diabetes treatments on patients' health after heart attack.

Impact of various diabetes treatments on patients' health after heart attack.

Benefit of exenatide has not yet been proven

Benefit of exenatide has not yet been proven

ACTOS associated with reduced risk of heart attack and stroke in patients with type 2 diabetes

ACTOS associated with reduced risk of heart attack and stroke in patients with type 2 diabetes

GlaxoSmithKline responds to Journal of the American Medical Association articles

GlaxoSmithKline responds to Journal of the American Medical Association articles

Takeda responds to FDA recommendation on Actos

Takeda responds to FDA recommendation on Actos

Metformin gets top grade for diabetes

Metformin gets top grade for diabetes

Colesevelam HCl hits diabetes with one-two punch

Colesevelam HCl hits diabetes with one-two punch

GSK strongly disagrees with conclusions reached in NEJM article on Avandia

GSK strongly disagrees with conclusions reached in NEJM article on Avandia

Race affects medication adherence

Race affects medication adherence

Latest diabetic medications more costly, but users have fewer hospital visits

Latest diabetic medications more costly, but users have fewer hospital visits

Chronic use of nitroglycerin for chest pain could lead to mitochondrial damage

Chronic use of nitroglycerin for chest pain could lead to mitochondrial damage

Oral medications may control symptoms of Type II diabetes in children just as well as insulin injections

Oral medications may control symptoms of Type II diabetes in children just as well as insulin injections

Takeda Pharmaceuticals submits NDA for a new oral diabetes medication

Takeda Pharmaceuticals submits NDA for a new oral diabetes medication

Chromium picolinate significantly reduces weight gain associated with common antidiabetic medication

Chromium picolinate significantly reduces weight gain associated with common antidiabetic medication

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

Exubera shows sustained blood glucose control in patients with type 2 diabetes

Exubera shows sustained blood glucose control in patients with type 2 diabetes